2023-04-21 01:02:37
“These are the first days of molecular imaging that are carried out in Patagonia and today the potential of this diagnostic technology was appreciated, but not only the potential for treatment. It is something that is in state-of-the-art development, we are working to be able to incorporate it into a near future to our practices. It is to accompany the growth of the new techniques but implemented with the preparation of the human resource and everything that has to accompany this process of excellence”, assured Schroeder.
In this context, Leben maintains strategic alliances with other institutions such as Siemens Healthcare, the Parará Model Clinic or the Baco Laboratory, who work on the subject and who seek to carry out joint actions to disseminate knowledge even within the country.
“There is nothing that can be done in Buenos Aires that cannot be done here. And the equipment is better than many centers in Buenos Aires, they have first-rate equipment in traditional nuclear medicine as well as in molecular imaging,” he stated. Margarita Núñez, PhD Key Opinion Leader and Clinical Matketing Manager, Molecular Imagingone of the speakers at the event.
the doctor Partha Ghosh, MD. Clinical Marketing Advisor at Siemens Healthcare, highlighted the great interest that exists among Neuquén professionals for innovation through nuclear medicine and assured that from the German company they are surprised to see the level of interest, training and investment in equipment that exists in Neuquén. “We would like to have more commitment and publish their results and commit more to get more of these systems, so that they continuously expand their branches, we would like to participate, discuss and support them in whatever way we can,” he said of the projected future collaborations.
For his part, Núñez reflected on the technophobic views sometimes raised by the accelerated advancement of technologies linked to health. “I think there is always resistance when new things appear, people are threatened with joblessness, they think that we are going to lose a job in the future, but in medicine artificial intelligence aims to achieve automation to process studies much faster than the conclusions be more objective, more reproducible between interobservers, it is a tool to support medicine and not be seen as a threat,” he said.
“It is important to keep up to date, but the philosophy of these technologies is to easily integrate into the routine and that it be something that facilitates the work and does not hinder it. Do not forget that all these technologies feed on the users’ own knowledge, so it is essential the contribution of professionals”, he added.
Guillermo Casale, Nuclear Department Manager of the Bacon Laboratory, highlighted the exchange with other professionals from different disciplines that allow different sciences united through the benefits of nuclear medicine to dialogue. “As a radiochemist I always learn from them and I bring my own, the good thing regarding nuclear medicine is to unite all the sciences in one, physics, chemistry, medicine and biology,” he said.
He added, in addition, that “Argentina has had a nuclear sciences institute since the 1950s and has trained half the world in this technology, that is why our genetics is to put the tools they need in the hands of doctors.” And he added: “The training of the Neuquinos is very high, they present work at an international level and that is why we work like them.”
Another of the speakers at the event was Mariela Agolti, Secretary-elect of WARMTH and Medical Director of the Nuclear Medicine Center of the Modelo Clinic in Paranáwho reflected on the challenges posed by the lack of authorization by the ANMAT of certain treatments that are already applied in other countries and that allow the advancement of nuclear medicine.
“Everything is a little slower here, but to the extent that this is known, there are patients who do not have other treatment options and having this option is very important,” he said, stressing the importance of the patients themselves having access to information regarding alternative treatments when all the official therapeutic options do not work with your case.
“There are always things to do from nuclear medicine,” said Agolti regarding the scenarios that are opening up for both diagnosis and treatment and that, thanks to advances in Neuquén, can now be done outside of Buenos Aires or other large urban centers. of the world.
1682057028
#Neuquén #received #main #references #molecular #medicine
